Concepedia

Mark Hatherill

MH

Statistics

Publications

159

Citations

14.6K

H-Index

63

Active since

1997

Affiliations

University of Cape Town(Current)

South African Tuberculosis Vaccine Initiative

Stellenbosch University

Aeras

South African Medical Research Council

Mark Hatherill is an author at University of Cape Town specializing in medicine, tuberculosis, and tuberculosis prevention.

ORCID

Top concepts

Publications per year

1997–2025

159

Publications

159

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial

Michèle Tameris, Mark Hatherill, Bernard Landry et al. · The Lancet · 2013 · 1K citations · Full text

, , +10

A blood RNA signature for tuberculosis disease risk: a prospective cohort study

Daniel E. Zak, Adam Penn‐Nicholson, Thomas J. Scriba et al. · The Lancet · 2016 · 795 citations · Full text

, , +10

Prevention of <i>M. tuberculosis</i> Infection with H4:IC31 Vaccine or BCG Revaccination

Elisa Nemes, Hennie Geldenhuys, Virginie Rozot et al. · New England Journal of Medicine · 2018 · 650 citations · Full text

Final Analysis of a Trial of M72/AS01 <sub>E</sub> Vaccine to Prevent Tuberculosis

Dereck Tait, Mark Hatherill, Olivier Van Der Meeren et al. · New England Journal of Medicine · 2019 · 561 citations · Full text

High-Dose Rifapentine with Moxifloxacin for Pulmonary Tuberculosis

Amina Jindani, Thomas S. Harrison, Andrew Nunn et al. · New England Journal of Medicine · 2014 · 436 citations · Full text

1–5 of 159